Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients
NCT02058680
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
PSA/IL-2/GM-CSF
Sponsor
OncBioMune Pharmaceuticals
Collaborators
[object Object]